Modulating BET Bromodomain Inhibitor ZEN-3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
2021 ◽
Keyword(s):
2021 ◽
2018 ◽
Vol 52
(6)
◽
pp. 420-429
◽
2018 ◽
Vol Volume 14
◽
pp. 2341-2347
◽